Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin

Andrew H. Talal; Ruei Chi Liu; Marija Zeremski; Rositsa Dimova; Lorna Dove; Daniel Pearce; Tarek Hassanein; Leleka Doonquah; David Aboulafia; Jorge Rodriguez; Hector Bonilla; Jeffrey Galpin; Judy A. Aberg; Barbara Johnston; Marshall J. Glesby; Ira M. Jacobson

doi:10.1097/QAI.0b013e3182324af9

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin

Andrew H. Talal, Ruei Chi Liu, Marija Zeremski, Rositsa Dimova, Lorna Dove, Daniel Pearce, Tarek Hassanein, Leleka Doonquah, David Aboulafia, Jorge Rodriguez, Hector Bonilla, Jeffrey Galpin, Judy A. Aberg, Barbara Johnston, Marshall J. Glesby, Ira M. Jacobson

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	261-268
Number of pages	8
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	58
Issue number	3
DOIs	https://doi.org/10.1097/QAI.0b013e3182324af9
State	Published - Nov 1 2011

ASJC Scopus Subject Areas

Infectious Diseases
Pharmacology (medical)

Keywords

anemia
granulocyte colony-stimulating factor
hepatitis C virus/HIV coinfection
neutropenia
recombinant human erythropoietin

Access to Document

10.1097/QAI.0b013e3182324af9

OpenUrl availability

Full text

Cite this

Talal, A. H., Liu, R. C., Zeremski, M., Dimova, R., Dove, L., Pearce, D., Hassanein, T., Doonquah, L., Aboulafia, D., Rodriguez, J., Bonilla, H., Galpin, J., Aberg, J. A., Johnston, B., Glesby, M. J., & Jacobson, I. M. (2011). Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin. Journal of Acquired Immune Deficiency Syndromes, 58(3), 261-268. https://doi.org/10.1097/QAI.0b013e3182324af9

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin. / Talal, Andrew H.; Liu, Ruei Chi; Zeremski, Marija et al.
In: Journal of Acquired Immune Deficiency Syndromes, Vol. 58, No. 3, 01.11.2011, p. 261-268.

Research output: Contribution to journal › Article › peer-review

Talal, AH, Liu, RC, Zeremski, M, Dimova, R, Dove, L, Pearce, D, Hassanein, T, Doonquah, L, Aboulafia, D, Rodriguez, J, Bonilla, H, Galpin, J, Aberg, JA, Johnston, B, Glesby, MJ & Jacobson, IM 2011, 'Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin', Journal of Acquired Immune Deficiency Syndromes, vol. 58, no. 3, pp. 261-268. https://doi.org/10.1097/QAI.0b013e3182324af9

Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D et al. Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin. Journal of Acquired Immune Deficiency Syndromes. 2011 Nov 1;58(3):261-268. doi: 10.1097/QAI.0b013e3182324af9

@article{36c2ee3b3b424450ac68d3aa938e4ccd,

title = "Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin",

keywords = "anemia, granulocyte colony-stimulating factor, hepatitis C virus/HIV coinfection, neutropenia, recombinant human erythropoietin",

author = "Talal, {Andrew H.} and Liu, {Ruei Chi} and Marija Zeremski and Rositsa Dimova and Lorna Dove and Daniel Pearce and Tarek Hassanein and Leleka Doonquah and David Aboulafia and Jorge Rodriguez and Hector Bonilla and Jeffrey Galpin and Aberg, {Judy A.} and Barbara Johnston and Glesby, {Marshall J.} and Jacobson, {Ira M.}",

year = "2011",

month = nov,

day = "1",

doi = "10.1097/QAI.0b013e3182324af9",

language = "English",

volume = "58",

pages = "261--268",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

number = "3",

}

TY - JOUR

T1 - Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin

AU - Talal, Andrew H.

AU - Liu, Ruei Chi

AU - Zeremski, Marija

AU - Dimova, Rositsa

AU - Dove, Lorna

AU - Pearce, Daniel

AU - Hassanein, Tarek

AU - Doonquah, Leleka

AU - Aboulafia, David

AU - Rodriguez, Jorge

AU - Bonilla, Hector

AU - Galpin, Jeffrey

AU - Aberg, Judy A.

AU - Johnston, Barbara

AU - Glesby, Marshall J.

AU - Jacobson, Ira M.

PY - 2011/11/1

Y1 - 2011/11/1

KW - anemia

KW - granulocyte colony-stimulating factor

KW - hepatitis C virus/HIV coinfection

KW - neutropenia

KW - recombinant human erythropoietin

UR - http://www.scopus.com/inward/record.url?scp=80054886875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054886875&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3182324af9

DO - 10.1097/QAI.0b013e3182324af9

M3 - Article

C2 - 21876446

AN - SCOPUS:80054886875

SN - 1525-4135

VL - 58

SP - 261

EP - 268

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 3

ER -

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this